Antonio Espinosa de Los Monteros-Zuniga
Overview
Explore the profile of Antonio Espinosa de Los Monteros-Zuniga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Godinez-Chaparro B, Rodriguez-Ramos M, Martinez-Lorenzana M, Gonzalez-Morales E, Perez-Ruiz K, Espinosa de Los Monteros-Zuniga A, et al.
Pharmacol Biochem Behav
. 2024 Dec;
247():173945.
PMID: 39675389
Pain is one of the principal non-motor symptoms of Parkinson's disease (PD), negatively impacting the patient's quality of life. This study aimed to demonstrate whether an effective dose of pramipexole...
2.
Condes-Lara M, Martinez-Lorenzana G, Espinosa de Los Monteros-Zuniga A, Lopez-Cordoba G, Cordova-Quiroga A, Flores-Bojorquez S, et al.
J Neurosci
. 2024 Mar;
44(17).
PMID: 38438259
Oxytocinergic transmission blocks nociception at the peripheral, spinal, and supraspinal levels through the oxytocin receptor (OTR). Indeed, a neuronal pathway from the hypothalamic paraventricular nucleus (PVN) to the spinal cord...
3.
Espinosa de Los Monteros-Zuniga A, Martinez-Lorenzana G, Condes-Lara M, Gonzalez-Hernandez A
ACS Chem Neurosci
. 2021 Aug;
12(16):3140-3147.
PMID: 34342984
Behavioral and electrophysiological data show that at the spinal level, oxytocin inhibits pain transmission by activation of oxytocin receptors (OTRs). Canonically, OTRs are coupled to G proteins, which induce a...
4.
Espinosa de Los Monteros-Zuniga A, Martinez-Lorenzana G, Condes-Lara M, Gonzalez-Hernandez A
Front Pharmacol
. 2020 Oct;
11:581544.
PMID: 33071793
The first few days post-surgery, patients experience intense pain, hypersensitivity and consequently tend to have minor locomotor activity to avoid pain. Certainly, injury to peripheral tissues produces pain and increases...
5.
Gamal-Eltrabily M, Espinosa de Los Monteros-Zuniga A, Manzano-Garcia A, Martinez-Lorenzana G, Condes-Lara M, Gonzalez-Hernandez A
J Neurosci
. 2020 Jun;
40(29):5669-5680.
PMID: 32571836
The rostral agranular insular cortex (RAIC) is a relevant structure in nociception. Indeed, recruitment of GABAergic activity in RAIC promotes the disinhibition of the locus ceruleus, which in turn inhibits...
6.
Gonzalez-Hernandez A, Espinosa de Los Monteros-Zuniga A, Martinez-Lorenzana G, Condes-Lara M
Exp Brain Res
. 2019 Sep;
237(11):2995-3010.
PMID: 31515587
The search for new ligands to treat neuropathic pain remains a challenge. Recently, oxytocin has emerged as an interesting molecule modulating nociception at central and peripheral levels, but no attempt...
7.
Espinosa de Los Monteros-Zuniga A, Izquierdo T, Quinonez-Bastidas G, Rocha-Gonzalez H, Godinez-Chaparro B
Pharmacol Biochem Behav
. 2016 Dec;
150-151:190-197.
PMID: 27984097
The neurobiology of neuropathic pain is caused by injury in the central or peripheral nervous system. Recent evidence points out that mangiferin shows anti-nociceptive effect in inflammatory pain. However, its...
8.
Izquierdo T, Espinosa de Los Monteros-Zuniga A, Cervantes-Duran C, Lozada M, Godinez-Chaparro B
Eur J Pharmacol
. 2013 Aug;
718(1-3):393-400.
PMID: 23973647
The purpose of this study was to investigate the possible antinociceptive effect of mangiferin, a glucosylxanthone present in Mangifera indica L., in inflammatory pain. Furthermore, we sought to investigate the...